1. |
|
|
2. |
- Meagher, N. S., et al.
(author)
-
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
- 2022
-
In: Clinical Cancer Research. - 1078-0432. ; 28:24, s. 5383-5395
-
Journal article (peer-reviewed)abstract
- Purpose: Advanced-stage mucinous ovarian carcinoma (MOC) has poor chemotherapy response and prognosis and lacks biomarkers to aid stage I adjuvant treatment. Differentiating primaryMOC from gastrointestinal (GI) metastases to the ovary is also challenging due to phenotypic similarities. Clinicopathologic and geneexpression data were analyzed to identify prognostic and diagnostic features. Experimental Design: Discovery analyses selected 19 genes with prognostic/diagnostic potential. Validation was performed through the Ovarian Tumor Tissue Analysis consortium and GI cancer biobanks comprising 604 patients with MOC (n = 333), mucinous borderline ovarian tumors ( MBOT, n = 151), and upper GI (n = 65) and lower GI tumors (n = 55). Results: Infiltrative pattern of invasion was associated with decreased overall survival (OS) within 2 years from diagnosis, compared with expansile pattern in stage I MOC [hazard ratio ( HR), 2.77; 95% confidence interval (CI), 1.04-7.41, P = 0.042]. Increased expression of THBS2 and TAGLN was associated with shorter OS in MOC patients (HR, 1.25; 95% CI, 1.04-1.51, P = 0.016) and (HR, 1.21; 95% CI, 1.01-1.45, P = 0.043), respectively. ERBB2 (HER2) amplification or high mRNA expression was evident in 64 of 243 (26%) of MOCs, but only 8 of 243 (3%) were also infiltrative (4/39, 10%) or stage III/IV (4/31, 13%). Conclusions: An infiltrative growth pattern infers poor prognosis within 2 years from diagnosis and may help select stage I patients for adjuvant therapy. High expression of THBS2 and TAGLN in MOC confers an adverse prognosis and is upregulated in the infiltrative subtype, which warrants further investigation. Anti-HER2 therapy should be investigated in a subset of patients. MOC samples clustered with upper GI, yet markers to differentiate these entities remain elusive, suggesting similar underlying biology and shared treatment strategies.
|
|
3. |
- Fabian, ID, et al.
(author)
-
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries
- 2021
-
In: The British journal of ophthalmology. - : BMJ. - 1468-2079 .- 0007-1161. ; 105:10, s. 1435-1443
-
Journal article (peer-reviewed)abstract
- The travel distance from home to a treatment centre, which may impact the stage at diagnosis, has not been investigated for retinoblastoma, the most common childhood eye cancer. We aimed to investigate the travel burden and its impact on clinical presentation in a large sample of patients with retinoblastoma from Africa and Europe.MethodsA cross-sectional analysis including 518 treatment-naïve patients with retinoblastoma residing in 40 European countries and 1024 treatment-naïve patients with retinoblastoma residing in 43 African countries.ResultsCapture rate was 42.2% of expected patients from Africa and 108.8% from Europe. African patients were older (95% CI −12.4 to −5.4, p<0.001), had fewer cases of familial retinoblastoma (95% CI 2.0 to 5.3, p<0.001) and presented with more advanced disease (95% CI 6.0 to 9.8, p<0.001); 43.4% and 15.4% of Africans had extraocular retinoblastoma and distant metastasis at the time of diagnosis, respectively, compared to 2.9% and 1.0% of the Europeans. To reach a retinoblastoma centre, European patients travelled 421.8 km compared to Africans who travelled 185.7 km (p<0.001). On regression analysis, lower-national income level, African residence and older age (p<0.001), but not travel distance (p=0.19), were risk factors for advanced disease.ConclusionsFewer than half the expected number of patients with retinoblastoma presented to African referral centres in 2017, suggesting poor awareness or other barriers to access. Despite the relatively shorter distance travelled by African patients, they presented with later-stage disease. Health education about retinoblastoma is needed for carers and health workers in Africa in order to increase capture rate and promote early referral.
|
|
4. |
- Sloot, Frea, et al.
(author)
-
Inventory of current EU paediatric vision and hearing screening programmes
- 2015
-
In: Journal of Medical Screening. - : SAGE Publications. - 0969-1413 .- 1475-5793. ; 22:2, s. 55-64
-
Journal article (peer-reviewed)abstract
- Objective: To examine the diversity in paediatric vision and hearing screening programmes in Europe. Methods: Themes for comparison of screening programmes derived from literature were used to compile three questionnaires on vision, hearing, and public health screening. Tests used, professions involved, age, and frequency of testing seem to influence sensitivity, specificity, and costs most. Questionnaires were sent to ophthalmologists, orthoptists, otolaryngologists, and audiologists involved in paediatric screening in all EU full-member, candidate, and associate states. Answers were cross-checked. Results: Thirty-nine countries participated; 35 have a vision screening programme, 33 a nation-wide neonatal hearing screening programme. Visual acuity (VA) is measured in 35 countries, in 71% of these more than once. First measurement of VA varies from three to seven years of age, but is usually before age five. At age three and four, picture charts, including Lea Hyvarinen, are used most; in children over four, Tumbling-E and Snellen. As first hearing screening test, otoacoustic emission is used most in healthy neonates, and auditory brainstem response in premature newborns. The majority of hearing testing programmes are staged; children are referred after 1–4 abnormal tests. Vision screening is performed mostly by paediatricians, ophthalmologists, or nurses. Funding is mostly by health insurance or state. Coverage was reported as >95% in half of countries, but reporting was often not first-hand. Conclusion: Largest differences were found in VA charts used (12), professions involved in vision screening (10), number of hearing screening tests before referral (1–4), and funding sources (8).
|
|
5. |
|
|
6. |
|
|
7. |
- BERTOLOTTO, L, et al.
(author)
-
RESULTS FROM (P)OVER-BAR-P-]PHI-PHI
- 1994
-
In: NUOVO CIMENTO DELLA SOCIETA ITALIANA DI FISICA A-NUCLEI PARTICLES AND FIELDS. - : EDITRICE COMPOSITORI BOLOGNA. ; , s. 2329-2337
-
Conference paper (peer-reviewed)abstract
- The reaction ($) over bar pp --> phi phi is investigated in the JETSET (PS202) experiment using an internal target in LEAR. Data have been analysed at a variety of beam momenta from 1.2 GeV/c to 2.0 GeV/c, corresponding to centre-of-mass energies between
|
|
8. |
- Chylek, P., et al.
(author)
-
Annual Mean Arctic Amplification 1970-2020: Observed and Simulated by CMIP6 Climate Models
- 2022
-
In: Geophysical Research Letters. - : American Geophysical Union (AGU). - 0094-8276 .- 1944-8007. ; 49:13
-
Journal article (peer-reviewed)abstract
- While the annual mean Arctic Amplification (AA) index varied between two and three during the 1970-2000 period, it reached values exceeding four during the first two decades of the 21st century. The AA did not change in a continuous fashion but rather in two sharp increases around 1986 and 1999. During those steps the mean global surface air temperature trend remained almost constant, while the Arctic trend increased. Although the "best" CMIP6 models reproduce the increasing trend of the AA in 1980s they do not capture the sharply increasing trend of the AA after 1999 including its rapid step-like increase. We propose that the first sharp AA increase around 1986 is due to external forcing, while the second step close to 1999 is due to internal climate variability, which models cannot reproduce in the observed time.
|
|
9. |
- Chylek, Petr, et al.
(author)
-
Arctic Amplification in the Community Earth System Models (CESM1 and CESM2)
- 2023
-
In: Atmosphere. - 2073-4433. ; 14:5
-
Journal article (other academic/artistic)abstract
- We compare the Arctic amplification (AA) produced by the two Community Earth System Models CESM1 and CESM2, members of the CEMIP5 (Coupled Models Intercomparison Project phase 5) and CEMIP6 collections, respectively. We find that the CESM1 model reproduces the recent high values of the AA deduced from the observed temperature much better than the CESM2. The correlation coefficient within the 1970–2012 time period between CESM1-simulated AA and the observed one is 0.47, while the CESM2 simulation leads to an anticorrelation of r = −0.53. Even the more successful model (CESM1) is not able to reproduce recent high AA values of 4–5. The main cause of this failure is the model’s overestimate of the rate of increase in the mean global temperature in years post 1990. When the CESM1 model’s simulated trend of the mean global temperature is replaced in the expression for the AA by the observed temperature trend, the correlation coefficient increases from 0.47 to 0.75. The CESM1 model is among the best north American models in AA simulation while the CESM2 model is among the least successful.
|
|
10. |
- Chylek, P., et al.
(author)
-
CMIP5 Climate Models Overestimate Cooling by Volcanic Aerosols
- 2020
-
In: Geophysical Research Letters. - : American Geophysical Union (AGU). - 0094-8276 .- 1944-8007. ; 47:3
-
Journal article (peer-reviewed)abstract
- We compare projections of the observed hemispherical mean surface temperature (HadCRUT4.6.0.0) and the ensemble mean of CMIP5 climate models' simulations on a set of standard regression model forcing variables. We find that the volcanic aerosol regression coefficients of the CMIP5 simulations are consistently significantly larger (by 40-49%) than the volcanic aerosol coefficients of the observed temperature. The probability that the observed differences are caused just by chance is much less than 0.01. The overestimate is due to the climate models' response to volcanic aerosol radiative forcing. The largest overestimate occurs in the winter season of each hemisphere. We hypothesize that the models' parameterization of aerosol-cloud interactions within ice and mixed phase clouds is a likely source of this discrepancy. Furthermore, the models significantly underestimate the effect of solar variability on temperature for both hemispheres. Plain Language Summary We compare the observed and climate models' simulated hemispherical mean temperature projections on a set of influencing factors. The influencing factors include the man-made greenhouse gases and aerosols as well as natural solar variability, volcanic eruptions, and internal climate variability. If the observed and model-simulated temperatures were the same, the projections would be very similar. We find that the projections are not similar. The climate models overestimate the cooling effect of volcanic activity and underestimate the effect of the variability of solar radiation. Our results point out that future models should improve the treatment of volcanic aerosols and solar variability to increase the reliability of climate change projections.
|
|